Remarkably, PCP-associated macrophages (PAMs) were emerging in PCP, characterized by high triggering receptor expressed on myeloid cells 2 (Trem2) expression, hypersecretion of inflammatory cytokines and inhibiting the proliferation of T cells, specifically dominant in the recovery stage of PCP. Here, TREM2 is linked to pneumocystosis.